Allarity Therapeutics, Inc. (ALLR)
0.96
-0.02
(-1.63%)
USD |
NASDAQ |
Nov 06, 10:15
Allarity Therapeutics Price to Book Value : 4.320 for Nov. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 4.391 |
| November 04, 2026 | 4.860 |
| November 03, 2026 | 5.085 |
| November 02, 2026 | 4.399 |
| October 30, 2026 | 3.916 |
| October 29, 2026 | 4.005 |
| October 28, 2026 | 4.275 |
| October 27, 2026 | 4.140 |
| October 26, 2026 | 4.118 |
| October 23, 2026 | 3.894 |
| October 22, 2026 | 3.809 |
| October 21, 2026 | 3.958 |
| October 20, 2026 | 3.941 |
| October 19, 2026 | 3.928 |
| October 16, 2026 | 4.027 |
| October 15, 2026 | 3.747 |
| October 14, 2026 | 3.930 |
| October 13, 2026 | 3.914 |
| October 12, 2026 | 3.870 |
| October 09, 2026 | 4.455 |
| October 08, 2026 | 4.418 |
| October 07, 2026 | 4.428 |
| October 06, 2026 | 4.434 |
| October 05, 2026 | 4.500 |
| October 02, 2026 | 4.680 |
| Date | Value |
|---|---|
| October 01, 2026 | 4.680 |
| September 30, 2026 | 4.725 |
| September 29, 2026 | 4.343 |
| September 28, 2026 | 4.357 |
| September 25, 2026 | 4.635 |
| September 24, 2026 | 4.905 |
| September 23, 2026 | 4.680 |
| September 22, 2026 | 4.995 |
| September 21, 2026 | 5.265 |
| September 18, 2026 | 5.445 |
| September 17, 2026 | 5.220 |
| September 16, 2026 | 5.197 |
| September 15, 2026 | 4.995 |
| September 14, 2026 | 5.265 |
| September 11, 2026 | 5.490 |
| September 10, 2026 | 5.624 |
| September 09, 2026 | 5.678 |
| September 08, 2026 | 5.624 |
| September 04, 2026 | 6.390 |
| September 03, 2026 | 6.434 |
| September 02, 2026 | 6.344 |
| September 01, 2026 | 6.390 |
| August 31, 2026 | 6.344 |
| August 28, 2026 | 6.344 |
| August 27, 2026 | 6.210 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.759 |
| Alnylam Pharmaceuticals, Inc. | 5.897 |
| Anika Therapeutics, Inc. | 1.638 |
| Savara, Inc. | 6.620 |
| Vericel Corp. | 7.061 |
Price to Book Value Related Metrics
| PS Ratio | 43.62 |
| Price | 0.96 |
| Earnings Yield | -81.92% |
| Market Cap | 15.27M |